MarketLine Blog

Posts about Pharmaceuticals

AstraZeneca agrees $6.9bn deal with Daiichi Sankyo: UK drug maker could dominate the future breast cancer therapy market

MarketLine

The joint development and commercialization of a new breast cancer therapy indicated for the treatment of HER-2 positive breast cancer has the potential to help the AstraZeneca in its quest for a larger oncology market share. If approved, it will join Lynparza (olaparib) – a PARP inhibitor marketed by AstraZeneca for the treatment of HER negative breast cancer. The addition of a new breast cancer therapy to the AstraZeneca product portfolio will almost certainly increase the company’s market share. Roche currently dominates the treatment of HER-2 positive breast cancer with… Read more

Beyond the pill: Pharma gets digital push

MarketLine

The global pharmaceutical market was worth $946.1bn in 2016, growing with a compound annual growth rate (CAGR) of 6.1% between 2012 and 2016. Healthy market growth and big margins in the traditional pharma industry are attracting a new generation of startup companies, who are using big data, sensors and artificial intelligence to revolutionize the way healthcare is delivered and they are not afraid to compete with the incumbent Big Pharma companies. Emerging digital technologies from the new generation start-ups are reshaping the traditional pharma landscape. By collecting enough data, directly… Read more

Overcrowded Unlicensed Medicines Industry: The NHS wins but smaller wholesalers lose

MarketLine

Unlicensed medicines, medicines which are not licensed in the UK, are becoming more popular. The market is growing due to the increasing demand for medicines which are not available on the NHS. These medicines may be too expensive or not in enough demand to justify bringing them in; the medicines may also not have the correct UK licensing to allow them to be sold in the country. There is also the potential problem with the supply chain which can result in a medicine being taken off the market temporarily and… Read more

Global generics market to experience double-digit growth through to 2021, says MarketLine

MarketLine

The global generics market has experienced dynamic growth in recent years, registering a compound annual growth rate (CAGR) of 11.1% between 2012 and 2016 to reach a value of $318 billion, according to data from research company MarketLine. The company’s latest report states that Asia-Pacific was comfortably the largest region in value terms, accounting for over 46% of the global total in 2016. The US followed with over 31%, while Europe continued to lag behind, contributing only 15.6%. The US once again reigned supreme as the single biggest country market,… Read more

Sequencing Quinoa: Food for thought

MarketLine

The pharmaceutical industry has been growing at a strong rate in recent years. One aspect of this market is that of the food supplement. The growing trend especially amongst the older populace and with the hectic lifestyles that are led in developed countries lends support to the supplement industry. The ability of scientists to understand the functions of different genes have assisted in the growth of specific markets and also in the changes to specific plant species. When looking at some of the historic plant species and how they have… Read more

Nude Makeup: Makeup is the new natural look

MarketLine

Historically, makeup was seen as a thing only used by grownups, however makeup being used by younger demographics is a growing trend. Trends now focus on teaching younger individuals how to use makeup with a recent quote suggesting that ‘nude makeup is the new natural’. Children are now being brought up to believe that makeup is natural and needed in order for them to look good. TV shows such as Toddlers and Tiaras further glamorize the use of makeup on children. Younger individuals using makeup has stimulated the appearance of… Read more

Brexit and Trump’s disastrous effect on science

MarketLine

2016 has been a rollercoaster of a year with regards to political incidences. With the UK voting in favor of leaving the EU in June 2016 and then a follow up of the US voting for President-elect Donald Trump in November of the same year, this has led to a degree of uncertainty in the scientific field. With funding at the forefront of scientific research and the advancement of scientific breakthroughs, the future has been thrown into turmoil as the individuals working in both countries, the US and the UK,… Read more

Generic drugs prices: Unscrupulous companies increase prices significantly

MarketLine

Generic drugs are identical in dose, strength, safety, efficacy, administration and intended use to their branded counterparts. They are produced after a product’s patent has expired, after 20 years. They are much cheaper to produce and these savings are passed on to the buyer: generics are much cheaper than their branded counterparts. An investigation by UK newspaper The Times, the findings of which were released in a June 2016 report, found that a small number of UK companies have made huge profits after increasing the prices of generic drugs. The… Read more